Search


Health Canada draft Guidance: Decentralized Clinical Trials
As clinical research continues to evolve, decentralized clinical trials (DCTs) are becoming increasingly important. By incorporating technologies such as telemedicine, remote monitoring, electronic consent, and home healthcare services, decentralized trials can reduce participant burden and improve access to research opportunities. Recognizing this shift, Health Canada launched a consultation on its Draft Guidance for Decentralized Clinical Trials (DCTs). Feedback from indust
Sharan Murugan
34 minutes ago3 min read


UK MHRA's Guidance: UK’s Decentralised Manufacture Framework: A Holistic Overview
In the evolving landscape of pharmaceutical manufacturing, Decentralised Manufacture has emerged as a pivotal approach, especially in...
Sharan Murugan
Jun 13, 20253 min read


USFDA Guidance: Decentralized Clinical Trials for Drugs, Biological Products, and Devices
Today (02 May 2023) the United States Food & Drug Administration's Center for Drug Evaluation and Research, Center for Biologics...
Sharan Murugan
May 2, 20232 min read
